Author

A. B. Nesburn

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

B. D. Kuppermann· 3 shared D. F. Tifrea· 3 shared L. BenMohamed· 3 shared N. R. Dhanushkodi· 3 shared R. A. Edwards· 3 shared C. J. Figueroa· 2 shared D. Gil· 2 shared H. Vahed· 2 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

B. D. Kuppermann

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cross-Protection Induced by Highly Conserved Human B, CD4+, and CD8+ T Cell Epitopes-Based Coronavirus Vaccine Against Severe Infection, Disease, and Death Caused by Multiple SARS-CoV-2 Variants of Concern

S. F. Prakash, N. R. Dhanushkodi, L. Zayou, I. C. Ibraim, A. Quadiri, P. G. Coulon, D. F. Tifrea, B. Suzler, M. Amin, A. Chilukuri, R. A. Edwards, H. Vahed, A. B. Nesburn, B. D. Kuppermann, J. B. Ulmer, , L. BenMohamed

This paper describes a multi-epitope vaccine that provides cross-protection against multiple SARS-CoV-2 variants by inducing functional T cell responses.

Frontiers in Immunology · Jan 22, 2024Peer-reviewedImmunology

High Frequencies of PD-1+TIM3+TIGIT+CTLA4+ Functionally Exhausted SARS-CoV-2-Specific CD4+ and CD8+ T Cells Associated with Severe Disease in Critically ill COVID-19 Patients

P.-G. A. Coulon, S. Prakash, N. R. Dhanushkodi, R. Srivastava, L. Zayou, D. F. Tifrea, R. A. Edwards, C. J. Figueroa, S. D. Schubl, L. Hsieh, A. B. Nesburn, B. D. Kuppermann, E. BAHRAOUI, H. Vahed, D. Gil, , L. BENMOHAMED

bioRxiv · Jan 30, 2022 · PreprintImmunology

Genome-Wide Asymptomatic B-Cell, CD4+ and CD8+ T-Cell Epitopes, that are Highly Conserved Between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Immune Targets for Pre-Emptive Pan-Coronavirus Vaccines

S. Prakash, S. Ruchi, P.-G. Coulon, N. R. Dhanushkodi, A. A. Chentoufi, D. F. Tifrea, R. A. Edwards, C. J. Figueroa, S. D. Schubl, L. Hsieh, M. J. Buchmeier, M. Bouziane, A. B. Nesburn, B. D. Kuppermann, L. BenMohamed

The paper identifies conserved B-cell and T-cell epitopes across multiple Coronaviruses to inform the development of a pan-Coronavirus vaccine.

bioRxiv · Sep 27, 2020Immunology